Mesalamine, also known as 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel diseases (IBD), primarily ulcerative colitis and Crohn's disease [1]. It works by reducing inflammation in the colon [1][2].
How does Mesalamine work in the body?
Mesalamine is believed to work through multiple mechanisms to reduce inflammation. These include inhibiting cyclooxygenase and lipoxygenase pathways, which are involved in the production of inflammatory mediators, and scavenging reactive oxygen species [2]. It may also modulate cytokine production and affect nuclear factor kappa B (NF-κB) signaling [2]. The drug is designed to be released in the colon, where it exerts its anti-inflammatory effects locally [3].
What conditions is Mesalamine prescribed for?
Mesalamine is primarily prescribed for the treatment of mild to moderate ulcerative colitis [1]. It is used both to induce remission of active disease and to maintain remission [1][3]. It is also used to treat Crohn's disease, particularly in cases involving the colon [1].
What are the different ways Mesalamine can be administered?
Mesalamine is available in various formulations to target different parts of the digestive tract. These include oral delayed-release tablets and capsules, oral extended-release capsules, and rectal suppositories and enemas [3][4]. The choice of formulation depends on the location and extent of the inflammation [3].
When does patent exclusivity for Mesalamine expire?
Patent exclusivity for mesalamine formulations varies depending on the specific product and its patent protection [5]. DrugPatentWatch.com tracks patent expirations for numerous drugs, including mesalamine [5].
Are there generic versions of Mesalamine available?
Yes, generic versions of mesalamine are available for many of its formulations. The availability of generics can impact the cost of treatment [6].
What are the potential side effects of Mesalamine?
Common side effects of mesalamine can include headache, nausea, abdominal pain, cramping, and diarrhea [1]. Less common but more serious side effects can include allergic reactions, kidney problems, and liver problems [1][7]. Patients should report any unusual or severe symptoms to their healthcare provider [1].
How does Mesalamine compare to other IBD treatments?
Mesalamine is generally considered a first-line treatment for mild to moderate ulcerative colitis [3]. Other treatments for IBD, depending on severity and location of disease, may include other aminosalicylates, corticosteroids, immunomodulators, and biologic therapies [3][8]. These other treatments often target different inflammatory pathways or have more potent immunosuppressive effects [3][8].